What is he best known for?
The fields of study he is best known for:
Antigen, Immunology, Melanoma, Adoptive cell transfer and Immunotherapy are his primary areas of study.
His studies deal with areas such as Molecular biology, Cytotoxic T cell and T-cell receptor as well as Antigen.
His T cell, Human leukocyte antigen and MART-1 Antigen study are his primary interests in Immunology.
The concepts of his Adoptive cell transfer study are interwoven with issues in Mutation, Cancer and In vivo.
He combines subjects such as Cancer research and Pathology with his study of Immunotherapy.
His work in Cancer research tackles topics such as Tumor antigen which are related to areas like Antibody.
His most cited work include:
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes (2452 citations)
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T Cell Transfer Immunotherapy (1361 citations)
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1 (1132 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Antigen, Immunology, Immunotherapy, Adoptive cell transfer and Cancer research.
The Antigen study combines topics in areas such as Molecular biology and T-cell receptor.
The study incorporates disciplines such as Cytotoxic T cell, Cancer and Melanoma in addition to Immunology.
His study in Immunotherapy is interdisciplinary in nature, drawing from both T lymphocyte, Chemotherapy and Cell therapy.
His research in Adoptive cell transfer intersects with topics in Interleukin 2, Internal medicine, Minigene and Oncology.
The various areas that Paul F. Robbins examines in his Cancer research study include Bioinformatics, Somatic cell, Mutation, Phenotype and Mutant.
He most often published in these fields:
- Antigen (49.48%)
- Immunology (45.88%)
- Immunotherapy (32.47%)
What were the highlights of his more recent work (between 2016-2021)?
- Cancer research (29.90%)
- Cancer (22.16%)
- T-cell receptor (26.29%)
In recent papers he was focusing on the following fields of study:
Paul F. Robbins mostly deals with Cancer research, Cancer, T-cell receptor, Antigen and Adoptive cell transfer.
His work deals with themes such as T cell, Cell, Mutant and Cancer immunotherapy, which intersect with Cancer research.
His T-cell receptor study incorporates themes from Molecular biology, MHC class I, Gene and Gastrointestinal cancer.
His Antigen study results in a more complete grasp of Immunology.
His Adoptive cell transfer research includes elements of CD8, Tumor-infiltrating lymphocytes, Immunotherapy, Minigene and Breast cancer.
His Immunotherapy study combines topics from a wide range of disciplines, such as Cytotoxic T cell, Blockade and Antibody.
Between 2016 and 2021, his most popular works were:
- Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer (298 citations)
- ‘Final common pathway’ of human cancer immunotherapy: targeting random somatic mutations (200 citations)
- Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer (184 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Immune system
Paul F. Robbins focuses on Immunotherapy, Antigen, Adoptive cell transfer, Cancer research and T cell.
Paul F. Robbins is investigating Immunotherapy as part of his Immunology and Cancer and Immunotherapy study.
He focuses mostly in the field of Cancer, narrowing it down to matters related to Blockade and, in some cases, Melanoma, Breast cancer, In vivo, Germline and Metastatic breast cancer.
His work investigates the relationship between Adoptive cell transfer and topics such as CD8 that intersect with problems in Molecular biology and Minigene.
His Cancer research research incorporates themes from Cell therapy, T-cell receptor and Cancer immunotherapy.
His T cell research incorporates elements of Gene expression profiling, Somatic cell, Human leukocyte antigen, Ovarian cancer and Epitope.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
